Pennsylvania Medical Marijuana DUI Laws
Why Moving Marijuana Out of Schedule I Could Fundamentally Change Pennsylvania's Medical Marijuana DUI Laws
For Pennsylvania medical marijuana patients, the potential rescheduling of marijuana from Schedule I to Schedule III could have consequences far beyond federal drug policy.
It could change the way Pennsylvania's DUI statute treats marijuana in a person's blood.
The reason is found directly in Pennsylvania's Vehicle Code.
Pennsylvania does not treat every controlled substance identically under its DUI statute. The law specifically distinguishes between:
Schedule I controlled substances;
Schedule II and Schedule III controlled substances that have not been medically prescribed; and
drugs that actually impair a driver's ability to safely operate a vehicle.
That distinction is especially important because Pennsylvania currently classifies marijuana as a Schedule I controlled substance.
If marijuana is removed from Schedule I and placed into Schedule III, Pennsylvania's DUI statute would no longer be dealing with marijuana under the Schedule I provision. If Pennsylvania correspondingly recognizes marijuana as Schedule III, the statutory distinction between prescribed and non-prescribed Schedule III substances becomes directly relevant.
This is not merely a theory developed by the cannabis industry.
A Pennsylvania government-hosted prosecutor-training document authored by David J. Drumheller, Esq., Traffic Safety Resource Prosecutor for the Pennsylvania District Attorneys Institute, specifically discusses how marijuana rescheduling would change DUI prosecution in Pennsylvania.
Pennsylvania's DUI Statute Is the Starting Point
The central statute is 75 Pa.C.S. § 3802(d), Pennsylvania's controlled-substance DUI provision.
Section 3802(d)(1) provides that a person may not drive, operate, or be in actual physical control of a vehicle when there is in the person's blood any amount of:
Schedule I controlled substance
Under 75 Pa.C.S. § 3802(d)(1)(i), the statute covers:
“any amount” of a Schedule I controlled substance.
There is no prescription exception written into this subsection.
That matters because Pennsylvania currently places marijuana in Schedule I.
Pennsylvania Treats Prescribed Schedule II and III Drugs Differently
The next subsection is where the legal distinction becomes particularly important.
Under 75 Pa.C.S. § 3802(d)(1)(ii), Pennsylvania's per-se controlled-substance provision applies to:
a Schedule II or Schedule III controlled substance “which has not been medically prescribed for the individual.”
That wording is fundamentally different from § 3802(d)(1)(i).
The statute therefore creates two categories:
Controlled-substance classification |
Pennsylvania § 3802(d)(1) treatment |
Schedule I |
Any amount in blood |
Schedule II or III, not medically prescribed |
Any amount in blood |
Schedule II or III, medically prescribed |
Not included in § 3802(d)(1)(ii) |
Any drug causing actual impairment |
Potential prosecution under § 3802(d)(2) |
This distinction is written directly into Pennsylvania's Vehicle Code.
Why Marijuana's Schedule I Classification Matters
Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act currently identifies marihuana as a Schedule I controlled substance.
Section 4 of the Act establishes Pennsylvania's controlled-substance schedules, and the Schedule I list includes “Marihuana.”
The statute's definition of marijuana is also broad and includes cannabis and preparations derived from the plant.
Consequently, marijuana's current Schedule I classification connects directly to § 3802(d)(1)(i) of the Vehicle Code.
That is why Pennsylvania medical marijuana patients have historically faced a different DUI situation from patients using prescribed Schedule II or III medications.
The Current Pennsylvania Rule Creates a Difficult Situation for Medical Marijuana Patients
Pennsylvania's Medical Marijuana Act created a state-regulated system allowing qualified patients to lawfully obtain and use medical cannabis.
But the Medical Marijuana Act did not automatically move marijuana out of Schedule I for purposes of Pennsylvania's controlled-substance scheduling system.
As a result, Pennsylvania courts have had to reconcile two different statutes:
The Medical Marijuana Act, which authorizes qualified patients to obtain and use medical cannabis under Pennsylvania law;
and
the Vehicle Code, which contains a separate prohibition concerning controlled substances in a driver's blood.
Pennsylvania appellate decisions have upheld the application of § 3802(d)(1) to marijuana while marijuana remains classified as Schedule I.
This is why a Pennsylvania medical marijuana authorization has not historically removed a patient from the Schedule I per-se DUI provision.
The Difference Between Per-Se DUI and Impairment DUI
This distinction is essential to understanding what Schedule III could change.
Per-Se Controlled-Substance DUI
Under § 3802(d)(1), the Commonwealth can establish a controlled-substance DUI based upon the presence of a qualifying controlled substance or metabolite in the blood, subject to the statute's requirements.
For a Schedule I substance, the statute does not require the Commonwealth to prove actual impairment under subsection (d)(1).
The classification itself is therefore extremely important.
Actual Impairment Is a Separate Offense
Pennsylvania also has 75 Pa.C.S. § 3802(d)(2).
That subsection provides that a person may not drive:
under the influence of a drug or combination of drugs to a degree which impairs the individual's ability to safely drive.
This is an impairment-based offense.
It asks a different question:
Was the driver's ability to safely operate the vehicle impaired?
That is different from simply asking whether a controlled substance covered by § 3802(d)(1) is present.
David J. Drumheller and the Pennsylvania District Attorneys Institute
One of the most important documents concerning this issue comes from the Pennsylvania government.
The document was authored by:
David J. Drumheller, Esq.
Traffic Safety Resource Prosecutor
Pennsylvania District Attorneys Institute
Drumheller's document discusses Pennsylvania's Medical Marijuana Act and the consequences of marijuana's potential rescheduling.
The document specifically explains that when marijuana is rescheduled from Schedule I to Schedule II or III, there would be a change in how DUI offenses involving marijuana are charged and prosecuted.
This is an important source because Drumheller was writing from the perspective of Pennsylvania's prosecutor-training system.
Most importantly, his analysis distinguishes between prescribed and non-prescribed marijuana after rescheduling.
The document explains that individuals without a prescription would remain subject to the per-se provision, while individuals with a valid prescription whose ability to safely drive was impaired could be charged under § 3802(d)(2), similar to other prescribed Schedule II or III drugs.
That is the legal distinction at the heart of this issue.
What Happens If Marijuana Moves to Schedule III?
Suppose marijuana is federally transferred from Schedule I to Schedule III and Pennsylvania subsequently recognizes the corresponding Schedule III classification.
The relevant Pennsylvania DUI provisions would then need to be read according to marijuana's new classification.
Today:
Marijuana → Schedule I → § 3802(d)(1)(i).
That subsection covers any amount of a Schedule I controlled substance.
After a Schedule III classification:
Marijuana → Schedule III → § 3802(d)(1)(ii).
But § 3802(d)(1)(ii) specifically concerns a Schedule II or III controlled substance that has not been medically prescribed for the individual.
That is the statutory change that could be extremely important to medical marijuana patients.
The Key Difference Is "Not Medically Prescribed"
The words “not medically prescribed” are not incidental.
They are part of the Pennsylvania General Assembly's statute.
For a Schedule II or III controlled substance, the per-se provision applies when the drug has not been medically prescribed.
That means Pennsylvania's law already recognizes a distinction between:
non-prescribed controlled substances
and
medically prescribed Schedule II or III controlled substances.
If marijuana becomes Schedule III and is legally prescribed under the applicable federal and state framework, the patient's prescribed marijuana would no longer be a Schedule I substance.
That would place the analysis under the statutory framework applicable to Schedule II and III substances.
This is precisely the change discussed in Drumheller's Pennsylvania prosecutor-training document.
This Does Not Mean "No DUI for Medical Marijuana"
There is an important distinction that should not be lost.
Schedule III would not give medical marijuana patients permission to drive while impaired.
Pennsylvania's § 3802(d)(2) would remain applicable to actual impairment.
In other words:
A prescription would not make impaired driving legal.
What changes is the legal treatment of the mere presence of the prescribed controlled substance.
That is a much narrower—and much more legally supportable—argument.
The Difference Can Be Explained With Two Hypothetical Patients
Patient One: Marijuana Remains Schedule I
A Pennsylvania patient lawfully obtains medical marijuana.
The patient later drives.
A blood test detects marijuana.
Because marijuana remains Schedule I, § 3802(d)(1)(i) addresses any amount of a Schedule I controlled substance in the blood.
The patient's medical authorization does not turn marijuana into a Schedule II or III substance.
Patient Two: Marijuana Becomes Schedule III
Now assume marijuana has been moved to Schedule III and Pennsylvania implements the corresponding classification.
The patient is legally prescribed the medication.
A blood test detects marijuana.
The substance is now Schedule III.
Section 3802(d)(1)(ii), however, applies to a Schedule II or III substance that has not been medically prescribed.
That means the prescribed Schedule III medication would not fall into the same statutory category as an unprescribed Schedule III drug.
If the patient was actually impaired, § 3802(d)(2) could still apply.
That is the distinction Pennsylvania's prosecutor-training material describes.
Pennsylvania Law Specifically Anticipates Marijuana Leaving Schedule I
The Pennsylvania Medical Marijuana Act contains an unusually relevant provision.
35 P.S. § 10231.2108 states that if the federal Controlled Substances Act is amended to remove marijuana from Schedule I, the Pennsylvania Department of Health must publish notice of the effective date of that federal amendment in the Pennsylvania Bulletin.
That is significant.
Pennsylvania's Medical Marijuana Act therefore expressly contemplates the possibility that federal law could remove marijuana from Schedule I.
This is not an unforeseen scenario in Pennsylvania law.
The legislature specifically addressed it.
Pennsylvania Also Has Authority to Synchronize Scheduling With Federal Law
Pennsylvania's Controlled Substance, Drug, Device and Cosmetic Act gives the Secretary of Health authority, under specified conditions, to reschedule controlled substances to coincide with federal law.
The Pennsylvania Bulletin has explained that under 35 P.S. § 780-103(c)(1), the Secretary may reschedule a controlled substance to coincide with federal law, including the federal Controlled Substances Act.
The Pennsylvania Bulletin further explains that a rescheduling to a lower schedule may take effect upon publication in the Pennsylvania Bulletin.
Pennsylvania has previously used this authority for an FDA-approved cannabis-derived drug, demonstrating that the mechanism is not merely theoretical.
The Federal Schedule III Proposal
The federal government has proposed moving marijuana from Schedule I to Schedule III.
The DEA's proposed rule explains that the Department of Health and Human Services recommended that marijuana be transferred to Schedule III after determining that marijuana has a currently accepted medical use and that its abuse and dependence characteristics supported placement in Schedule III rather than Schedule II.
That federal determination is significant because Schedule I and Schedule III have fundamentally different statutory definitions.
Under Pennsylvania's controlled-substance statute, Schedule I is associated with a finding of:
high potential for abuse;
no currently accepted medical use in the United States; and
lack of accepted safety for use under medical supervision.
Schedule III, by contrast, is defined around a lower potential for abuse, documented and currently accepted medical use, and lower levels of physical or psychological dependence.
Therefore, moving marijuana from Schedule I to Schedule III would not simply change a number on a federal list.
It would represent a fundamentally different controlled-substance classification.
Why This Matters Under Pennsylvania Law
Pennsylvania's DUI statute incorporates Pennsylvania's controlled-substance schedules directly into § 3802(d)(1).
The statute specifically refers to:
Schedule I controlled substances, and
Schedule II or III controlled substances that have not been medically prescribed.
That means the classification of marijuana is directly connected to the DUI analysis.
This is why rescheduling could matter so much to Pennsylvania patients.
THC Detection and Actual Impairment Are Not the Same Question
The legal distinction becomes even more important because cannabis testing is not the same as measuring current impairment.
A laboratory can detect cannabinoids or metabolites after the period of acute intoxication has passed.
This creates an important difference between:
evidence that cannabis was consumed
and
evidence that the person was impaired while driving.
For medical marijuana patients, that distinction is especially important because patients may use cannabis repeatedly as part of an ongoing medical regimen.
A positive test does not automatically answer the question:
Was this person impaired at the time they were driving?
That is the question addressed by Pennsylvania's impairment provision, § 3802(d)(2).
Why Schedule III Could Change the Legal Question
Under the current Schedule I framework, the legal question can be heavily focused on whether marijuana is present.
After a Schedule III classification, a legally prescribed patient would fall into a different statutory category.
The legal analysis would move toward the distinction between:
prescribed versus non-prescribed use
and, independently,
impaired versus not impaired driving.
That is precisely the framework described by David J. Drumheller in the Pennsylvania District Attorneys Institute material.
What Happens to a Person Without a Prescription?
Schedule III would not eliminate Pennsylvania's per-se controlled-substance DUI law.
Section 3802(d)(1)(ii) would still apply to a Schedule II or III controlled substance that has not been medically prescribed.
Therefore, if marijuana becomes Schedule III:
Non-prescribed marijuana
The per-se provision could still apply.
Medically prescribed marijuana
The prescription exception contained in § 3802(d)(1)(ii) becomes relevant.
Actual impairment
§ 3802(d)(2) remains available regardless of the prescription issue when the person's ability to drive safely is impaired.
This is why saying “Schedule III eliminates marijuana DUIs” would be inaccurate.
The more precise statement is:
Schedule III could remove a medically prescribed marijuana patient from Pennsylvania's current Schedule I per-se DUI category, while leaving impairment-based DUI enforcement intact.
That is the legally supportable claim.
Pennsylvania's Own Prosecutor Training Material Supports This Interpretation
The strongest Pennsylvania-specific evidence comes from the document authored by David J. Drumheller, Esq.
His analysis explains that marijuana's rescheduling would change how DUI cases are charged and prosecuted.
Under the existing Schedule I classification, marijuana falls under the per-se provision.
After rescheduling to Schedule II or III:
non-prescribed marijuana would remain subject to the applicable per-se provision;
prescribed marijuana would be treated differently; and
a patient whose ability to safely drive was impaired could be charged under § 3802(d)(2), just like someone using another prescribed Schedule II or III drug.
This is particularly important because it comes from a Pennsylvania prosecutor-training source rather than a cannabis advocacy organization.
Pennsylvania's Law Creates a Clear Classification-Based Structure
The statutory framework can therefore be summarized this way:
Current marijuana classification
Schedule I
↓
75 Pa.C.S. § 3802(d)(1)(i)
↓
Any amount of a Schedule I controlled substance.
Potential future classification
Schedule III
↓
75 Pa.C.S. § 3802(d)(1)(ii)
↓
Schedule II or III substance not medically prescribed.
Separate impairment provision
75 Pa.C.S. § 3802(d)(2)
↓
Driving while under the influence of a drug to a degree that impairs the ability to safely drive.
That is why marijuana's classification is so important.
What Pennsylvania Patients Should Watch For
If federal marijuana rescheduling becomes final, Pennsylvania patients should watch for the following:
1. Federal rescheduling becomes effective
The federal government must complete the administrative process and make the Schedule III classification effective.
2. Pennsylvania recognizes the new classification
Pennsylvania law provides mechanisms for its controlled-substance scheduling system to respond to federal scheduling changes.
3. Pennsylvania publishes the required notice
The Medical Marijuana Act specifically addresses federal removal of marijuana from Schedule I and requires the Department of Health to publish notice of the effective date.
4. Pennsylvania courts interpret the new classification
The ultimate application of § 3802(d) will depend on the actual statutory and regulatory changes and subsequent judicial interpretation.
The Bottom Line
Pennsylvania's medical marijuana DUI issue is directly connected to marijuana's classification as a Schedule I controlled substance.
Under 75 Pa.C.S. § 3802(d)(1)(i), Pennsylvania prohibits driving when there is any amount of a Schedule I controlled substance in the person's blood.
Pennsylvania's controlled-substance statute currently places marijuana in Schedule I.
But Pennsylvania treats Schedule II and III substances differently.
Under 75 Pa.C.S. § 3802(d)(1)(ii), the per-se provision applies to a Schedule II or III controlled substance that has not been medically prescribed for the individual.
That distinction is why moving marijuana from Schedule I to Schedule III could be so significant for Pennsylvania medical marijuana patients.
And Pennsylvania's own prosecutor-training material—authored by David J. Drumheller, Esq., Traffic Safety Resource Prosecutor for the Pennsylvania District Attorneys Institute—specifically explains that rescheduling marijuana to Schedule II or III would change how marijuana DUI cases are charged and prosecuted. The document states that a person with a valid prescription whose ability to safely drive is impaired could be charged under § 3802(d)(2), rather than being treated under the same per-se framework applicable to non-prescribed Schedule II/III substances.
This does not mean that a medical marijuana patient would receive permission to drive while impaired.
It means something much more specific:
If marijuana is moved from Schedule I to Schedule III and Pennsylvania recognizes that new classification, a medically prescribed marijuana product would no longer be classified as a Schedule I substance for purposes of § 3802(d)(1)(i). The prescription distinction in § 3802(d)(1)(ii) would then become directly relevant, while actual impairment would remain prohibited under § 3802(d)(2).
Pennsylvania law itself anticipates federal removal of marijuana from Schedule I, and Pennsylvania has statutory authority to coordinate its controlled-substance scheduling with federal law.
For Pennsylvania medical marijuana patients, that could represent a fundamental change in the difference between testing positive for cannabis and being legally found to have driven while impaired by cannabis.
Frequently Asked Questions
Will Schedule III make marijuana DUI charges disappear in Pennsylvania?
No. The more precise effect is that Schedule III could change which subsection of Pennsylvania's DUI statute applies to medically prescribed marijuana. Actual impairment can still be prosecuted under § 3802(d)(2).
Why does Schedule I matter so much?
Because § 3802(d)(1)(i) specifically covers any amount of a Schedule I controlled substance in the blood. Marijuana is currently classified as Schedule I under Pennsylvania's controlled-substance law.
What is different about Schedule III?
Section 3802(d)(1)(ii) applies to Schedule II or III controlled substances that have not been medically prescribed.
Who is David J. Drumheller?
David J. Drumheller, Esq. is identified in the Pennsylvania government-hosted document as the Traffic Safety Resource Prosecutor for the Pennsylvania District Attorneys Institute. His training material specifically discusses marijuana rescheduling and its effect on Pennsylvania DUI prosecution.
What did Drumheller say about rescheduling?
His analysis explains that rescheduling marijuana from Schedule I to Schedule II or III would change how DUI cases are charged and prosecuted. He distinguishes non-prescribed marijuana from marijuana used pursuant to a valid prescription and explains that an impaired prescribed patient could be charged under § 3802(d)(2).
Here a link to the document i refer to
https://drive.google.com/file/d/19pfpPQqo_Thv5CC6pNZuDYfFOhZTFspk/view?usp=sharing
Does Pennsylvania law anticipate marijuana leaving Schedule I?
Yes. 35 P.S. § 10231.2108 specifically addresses the federal removal of marijuana from Schedule I and requires Pennsylvania's Department of Health to publish notice of the effective date in the Pennsylvania Bulletin.
Can Pennsylvania change its controlled-substance schedules when federal law changes?
Pennsylvania law gives the Secretary of Health authority, under specified conditions, to reschedule controlled substances to coincide with federal law. Pennsylvania's own Bulletin has described this authority under 35 P.S. § 780-103(c)(1).
Does a medical marijuana card automatically equal a federal prescription today?
No. That distinction should not be blurred. Pennsylvania's medical marijuana program provides state authorization to obtain medical cannabis, while the federal prescription framework is a separate legal issue. The Drumheller document discusses the effect of a valid prescription in the context of rescheduling.
Would a medical marijuana patient be allowed to drive while impaired after Schedule III?
No. Pennsylvania's § 3802(d)(2) separately prohibits driving under the influence of a drug to a degree that impairs the person's ability to drive safely.
Legal Disclaimer
This article is an educational discussion of Pennsylvania statutes, government documents, and publicly available legal authorities. It is not legal advice and does not create an attorney-client relationship. DUI law can depend on the specific facts of a case, the exact substance detected, laboratory testing, applicable regulations, and subsequent court decisions. Anyone facing a DUI investigation or prosecution should consult a Pennsylvania attorney.
Citation List:
[1] Pennsylvania General Assembly, 75 Pa.C.S. § 3802 — Driving under influence of alcohol or controlled substance.
[2] Pennsylvania General Assembly, 35 P.S. § 780-104 — Schedules of Controlled Substances.
[3] Pennsylvania General Assembly, 35 P.S. § 10231.2108 — Medical Marijuana Act, Notice.
[4] Pennsylvania General Assembly / Pennsylvania Bulletin, 35 P.S. § 780-103(c)(1) — authority to reschedule controlled substances to coincide with federal law.
[5] David J. Drumheller, Esq., Traffic Safety Resource Prosecutor, Pennsylvania District Attorneys Institute — Medical Marijuana Act / DUI Training Material.
[6] U.S. Drug Enforcement Administration, Schedules of Controlled Substances: Rescheduling of Marijuana, proposed rule.
[7] Pennsylvania General Assembly, Vehicle Code blood-testing provisions concerning Schedule I and non-prescribed Schedule II/III controlled substances and metabolites.
